scholarly article | Q13442814 |
P356 | DOI | 10.1309/BL7EMW66LQX6GFRP |
P698 | PubMed publication ID | 16191507 |
P50 | author | Gunnar B Kristensen | Q90928617 |
Anne-Lise Børresen-Dale | Q11958220 | ||
Åslaug Helland | Q38155382 | ||
Jahn M. Nesland | Q73925706 | ||
P2093 | author name string | Yun Wang | |
Ruth Holm | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 392-401 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | American Journal of Clinical Pathology | Q15750224 |
P1476 | title | Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas | |
P478 | volume | 124 |
Q54411632 | Analysis of PTEN, BRAF and PI3K status for determination of benefit from cetuximab therapy in metastatic colorectal cancer patients refractory to chemotherapy with wild-type KRAS. |
Q35847701 | Blocking epidermal growth factor receptor activation by 3,3'-diindolylmethane suppresses ovarian tumor growth in vitro and in vivo |
Q38652339 | EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review |
Q36614450 | Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients |
Q54583226 | Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type. |
Q79915423 | Expression of the chromatin remodeling factor Rsf-1 is upregulated in ovarian carcinoma effusions and predicts poor survival |
Q34587948 | Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer |
Q43280944 | Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer |
Q34557233 | Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization |
Q37269642 | Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis |
Q34586019 | Multiple genetic alterations within the PI3K pathway are responsible for AKT activation in patients with ovarian carcinoma |
Q38226577 | Oncogenes associated with drug resistance in ovarian cancer |
Q36121260 | PI3K expression and PIK3CA mutations are related to colorectal cancer metastases |
Q35095308 | PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup |
Q37328373 | Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies |
Q46159400 | Prognostic value and clinicopathological significance of p53 and PTEN in epithelial ovarian cancers |
Q44929440 | Prognostic value of HER-2/neu expression in epithelial ovarian cancer: a meta-analysis |
Q80010199 | Prognostic value of PIK3CA and phosphorylated AKT expression in ovarian cancer |
Q35791117 | Relevant molecular markers and targets |
Q42055866 | Targeting the fanconi anemia pathway to identify tailored anticancer therapeutics. |
Q36785983 | The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer |
Q89861767 | The Expression of ERK1/2 in Female Yak (Bos grunniens) Reproductive Organs |
Q33906083 | The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. |
Q33577824 | The role of the PTEN/PI3K/Akt pathway on prognosis in epithelial ovarian cancer: a meta-analysis |
Search more.